Prosecution Insights
Last updated: October 04, 2026
Application No. 18/844,200

Delivery Shaft Assembly for Delivery of an Implant

Non-Final OA §112
Filed
Sep 05, 2024
Priority
Mar 09, 2022 — EU 22161176.7 +1 more
Examiner
ZIMBOUSKI, ARIANA
Art Unit
Tech Center
Assignee
Istar Medical
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
417 granted / 612 resolved
+8.1% vs TC avg
Strong +31% interview lift
Without
With
+31.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
24 currently pending
Career history
630
Total Applications
across all art units

Statute-Specific Performance

§101
3.6%
-36.4% vs TC avg
§103
45.5%
+5.5% vs TC avg
§102
13.0%
-27.0% vs TC avg
§112
31.2%
-8.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 612 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 30 is objected to because of the following informalities: the list comprising dashes should be removed and a comma should be included between the third and fourth lines. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 24-29 and 32 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 24, the phrase "preferably" renders the claim indefinite because it is unclear whether the limitations following the phrase are part of the claimed invention. See MPEP § 2173.05(d). Claims 25-29 are rejected as dependents of claim 24. Regarding claims 25 and 26, the limitation “a perpendicular portion” renders the claim indefinite as it is unclear whether this is the same or different than the “a perpendicular portion” in claim 24, from which claims 25 and 26 depend. Claim 27 is rejected as a dependent of claim 26. Regarding claim 32, the limitation “delivery shaft assembly of claim 1” renders the claim indefinite as claim 1 is cancelled and a claim cannot depend from a cancelled claim. Furthermore, it is unclear exactly which claim that claim 32 should depend from. Allowable Subject Matter Claims 16-23 and 31 are allowable; claims 24-29 and 32 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action; and claim 30 would be allowable if rewritten or amended to overcome the objection set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: the closest prior art found is Vandiest et al. (US 2019/0038462), which discloses a delivery shaft assembly having a proximal end and a distal end for delivery of an ocular implant (see Figs. 3-7), wherein: the delivery shaft assembly comprises a delivery shaft 330 having a wall defining lumen configured for holding the ocular implant 200, and an adapter 360 at the proximal end of the delivery shaft configured for attachment to an inserter tool 320 for deployment of the implant (see par. 102); wherein the delivery shaft comprises a distal section 330a; wherein the delivery shaft is provided with an axially longitudinal observation fenestration at least partly disposed in the distal compliant section allowing visualization of the implant from an anterior side of the delivery shaft (see par. 94, 106, shaft is transparent); wherein the delivery shaft comprises a distal tip section having an atraumatic distal tip (see par. 152). Vandiest does not disclose the distal compliant section is repeatably bendable, compliant, and biased in a curve in a first plane; wherein the wall in the distal compliant section is provided with a plurality of flexibility slots that impart the bendability, wherein the wall in the distal tip section comprises a pair of cut outs that define a restricting flap and an extension body, wherein, the restricting flap and extension body co- operate to form a wedge-shaped distal tip, and the restricting flap is moveable around a living hinge between an open state and an occluding state and is biased in the occluding state. While additional prior art could be found disclosing the distal compliant section being repeatably bendable, compliant, and biased in a curve in a first plane and the provided with a plurality of flexibility slots that impart the bendability, such as disclosed by Hiorth (US 2022/0288356) and Eastwood et al. (US 2020/0015839), none of these prior art disclose the required restricting flap and extension body wherein the restricting flap is moveable around a living hinge between an open state and an occluding state and is biased in the occluding state. Raschdorf et al. (CN 102395331) discloses a spring arm 606 that is biased toward another spring arm 606 such that when a rod is inserted the inward bias of the spring arm is pushed outward, thereby preventing the upper shaft 600 separated from the lower part shaft 614 (see par. 109-112, Fig. 83A-83B). However, due to the different configuration of the device of Raschdorf being in a device for tissue or valve repair and not for delivery of an ocular implant, with the arms, similar to flaps, being use to prevent parts of shafts from separating, which would not be beneficial to other prior art mentioned above or the claimed invention, one of ordinary skill would not be motivated to modify teachings described above to add a restricting flap and an extension body as disclosed by Raschdorf. Vetter et al. (US 2016/0166240) discloses a medical device used for aspiration and soft tissue biopsy procedures that includes a distal tip with a pair of cut outs 466 that define a restricting flap/beak and the flap/beak movable around a living hinge (see par. 25), however, the beaks are biased in the open configuration (see par. 25) and not an occluding state. Due to the lack of biasing in the occluding state and the purpose of the beaks in biopsy procedures, one of ordinary skill in the art would not be motivated to modify the device disclosed by Vandiest, Hiorth, and Eastwood to include all the teachings of claim 16. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ARIANA ZIMBOUSKI whose telephone number is (303)297-4665. The examiner can normally be reached 8:30 - 5:00 PST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, REBECCA E EISENBERG can be reached at (571) 270-5879. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ARIANA ZIMBOUSKI/Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Sep 05, 2024
Application Filed
Sep 17, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740893
Eye Disease Implant Device Having Formation Pressure in Anterior Chamber Adjusted
3y 9m to grant Granted Sep 22, 2026
Patent 12714548
URETHRAL BARRIER DEVICE AND METHOD OF USE
2y 8m to grant Granted Aug 25, 2026
Patent 12702621
PHARMACEUTICAL CONTAINERS INCLUDING HIGH CTE SEALING ASSEMBLY ENCIRCLING OUTER SURFACE OF CONTAINER
3y 9m to grant Granted Aug 11, 2026
Patent 12702815
EXTRACORPOREAL CIRCULATION CIRCUIT
3y 0m to grant Granted Aug 11, 2026
Patent 12691037
MEDICINAL FLUID DELIVERY DEVICE
2y 10m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+31.0%)
3y 4m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 612 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month